Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials

医学 膀胱切除术 围手术期 随机对照试验 膀胱癌 优势比 置信区间 背景(考古学) 荟萃分析 生活质量(医疗保健) 内科学 泌尿科 外科 癌症 古生物学 护理部 生物
作者
Pramit Khetrapal,Joanna Wong,Wei Phin Tan,Thiara Rupasinghe,Wei Shen Tan,Stephen B. Williams,Stephen A. Boorjian,Carl Wijburg,Dipen J. Parekh,Peter Wiklund,Nikhil Vasdev,Muhammad Shamim Khan,Khurshid A. Guru,James W.F. Catto,John D. Kelly
出处
期刊:European Urology [Elsevier]
卷期号:84 (4): 393-405 被引量:64
标识
DOI:10.1016/j.eururo.2023.04.004
摘要

Differences in recovery, oncological, and quality of life (QoL) outcomes between open radical cystectomy (ORC) and robot-assisted radical cystectomy (RARC) for patients with bladder cancer are unclear.This review aims to compare these outcomes within randomized trials of ORC and RARC in this context. The primary outcome was the rate of 90-d perioperative events. The secondary outcomes included operative, pathological, survival, and health-related QoL (HRQoL) measures.Systematic literature searches of MEDLINE, Embase, Web of Science, and clinicaltrials.gov were performed up to May 31, 2022.Eight trials, reporting 1024 participants, were included. RARC was associated with a shorter hospital length of stay (LOS; mean difference [MD] 0.21, 95% confidence interval [CI] 0.03-0.39, p = 0.02) than and similar complication rates to ORC. ORC was associated with higher thromboembolic events (odds ratio [OR] 1.84, 95% CI 1.02-3.31, p = 0.04). ORC was associated with more blood loss (MD 322 ml, 95% CI 193-450, p < 0.001) and transfusions (OR 2.35, 95% CI 1.65-3.36, p < 0.001), but shorter operative time (MD 76 min, 95% CI 39-112, p < 0.001) than RARC. No differences in lymph node yield (MD 1.07, 95% CI -1.73 to 3.86, p = 0.5) or positive surgical margin rates (OR 0.95, 95% CI 0.54-1.67, p = 0.9) were present. RARC was associated with better physical functioning or well-being (standardized MD 0.47, 95% CI 0.29-0.65, p < 0.001) and role functioning (MD 8.8, 95% CI 2.4-15.1, p = 0.007), but no improvement in overall HRQoL. No differences in progression-free survival or overall survival were seen. Limitations may include a lack of generalization given trial patients.RARC offers various perioperative benefits over ORC. It may be more suitable in patients wishing to avoid blood transfusion, those wanting a shorter LOS, or those at a high risk of thromboembolic events.This study compares robot-assisted keyhole surgery with open surgery for bladder cancer. The robot-assisted approach offered less blood loss, shorter hospital stays, and fewer blood clots. No other differences were seen.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhh发布了新的文献求助10
刚刚
李健应助唐唯一采纳,获得10
刚刚
CCR发布了新的文献求助10
刚刚
叶楠发布了新的文献求助10
1秒前
浮山发布了新的文献求助10
1秒前
1秒前
1秒前
科研通AI2S应助雾野与晚风采纳,获得10
2秒前
852应助雾野与晚风采纳,获得10
2秒前
wanci应助雾野与晚风采纳,获得10
2秒前
淡定宛丝发布了新的文献求助10
2秒前
英俊的铭应助雾野与晚风采纳,获得10
2秒前
研友_VZG7GZ应助雾野与晚风采纳,获得10
2秒前
小马甲应助雾野与晚风采纳,获得10
2秒前
wanci应助雾野与晚风采纳,获得10
2秒前
Jasper应助雾野与晚风采纳,获得10
2秒前
爆米花应助雾野与晚风采纳,获得10
2秒前
斯文败类应助默默的听枫采纳,获得10
3秒前
3秒前
善学以致用应助tkxfy采纳,获得10
3秒前
3秒前
爱学习的结香酱完成签到,获得积分10
3秒前
4秒前
4秒前
传奇3应助王饱饱采纳,获得10
4秒前
4秒前
Cuttle01完成签到,获得积分20
4秒前
英俊的铭应助YS采纳,获得10
4秒前
从容不平完成签到,获得积分10
4秒前
4秒前
寻觅发布了新的文献求助10
5秒前
ycp完成签到,获得积分10
5秒前
gyh完成签到,获得积分20
5秒前
tomoe发布了新的文献求助10
5秒前
6秒前
6秒前
wang完成签到,获得积分10
6秒前
6秒前
6秒前
lmkpx完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Modified letrozole versus GnRH antagonist protocols in ovarian aging women for IVF: An Open-Label, Multicenter, Randomized Controlled Trial 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6063003
求助须知:如何正确求助?哪些是违规求助? 7895366
关于积分的说明 16313096
捐赠科研通 5206329
什么是DOI,文献DOI怎么找? 2785311
邀请新用户注册赠送积分活动 1767947
关于科研通互助平台的介绍 1647471